Diagnosis and therapy of hyperandrogenism.
Diagnostic categories in hyperandrogenism include polycystic ovary syndrome (PCOS) and its variants, adrenal and ovarian steroidogenic enzyme deficiencies, adrenal and ovarian androgen secreting tumours and other endocrine disorders such as hyperprolactinaemia, Cushing syndrome and acromegaly. About 95% of hyperandrogenic women will have PCOS. Endometrial hyperplasia can be prevented in hyperandrogenic, anovulatory women by the oral contraceptive pill or progestins. Hirsutism is best treated by a combination of the oral contraceptive pill and an anti-androgen. The first line of therapy for ovulation induction is clomiphene citrate, with human menopausal gonadotrophins (hMG) or laparoscopic ovulation induction reserved for clomiphene failures. hMG together with gonadotrophin-releasing hormone agonist may decrease the risk of spontaneous abortion following ovulation induction in PCOS. Weight loss should be vigorously encouraged to ameliorate the metabolic consequences of PCOS.
Barnes
R B
RB
Department of Obstetries and Gynecology, University of Chicago, IL 60637, USA.
D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000172:deficiency; D016889:Endometrial Neoplasms / Q000517:prevention & control; D005260:Female; D006628:Hirsutism / Q000628:therapy; D006801:Humans; D017588:Hyperandrogenism / Q000175:diagnosis / Q000628:therapy; D011085:Polycystic Ovary Syndrome / Q000209:etiology / Q000628:therapy; D011944:Receptors, Androgen / Q000502:physiology
D000726:Androgen Antagonists; D000728:Androgens; D011944:Receptors, Androgen